Under the terms of the agreement, Sun Pharma has been granted the rights to market Sovateltide in India using the brand name Tyvalzi™ (Sovateltide). In return, Pharmazz will receive upfront payments, milestone payments, and royalties as stipulated in the agreement.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment